Open Orphan Coronavirus and RSV human challenge studies underway (Interviews)

Open Orphan plc (LON:ORPH) in a string of positive news releases catch up with DirectorsTalk to discuss two human study challenges. Executive Chairman Cathal Friel joins DirectorsTalk to discuss the commencement of development of world’s first commercial human coronavirus challenge study model. Cathal provides us with more details on […]

Click here to view original web page at